Outcome
    Strong Evidence
    Effectiveness 5/5

    Folate (Vitamin B9) for Fertility Support Female

    Folate before conception and in early pregnancy prevents neural tube defects — one of the most proven supplement interventions in medicine. It also supports ovulatory function.

    Overview

    Folate's place in preconception care is settled, though the reason is often misstated. Its unambiguous, guideline-backed benefit is preventing neural tube defects, which requires adequate status before conception because the neural tube closes by around day 28 — often before pregnancy is confirmed. That is why supplementation starts when trying to conceive, not when a test turns positive. Beyond that, observational and secondary trial data associate higher folate intake with better ovulatory function, improved oocyte quality and higher live birth rates in assisted reproduction, and lower homocysteine in follicular fluid. These signals are consistent but not proof of causation, and folate is not a treatment for infertility.

    Verdict

    Strong yes

    Preconception folate is strongly recommended and clearly prevents neural tube defects. Fertility-specific benefits — ovulatory function and assisted reproduction outcomes — are supported by observational and secondary data rather than dedicated trials.

    How It Works

    Folate carries one-carbon units for the synthesis of purines and thymidylate, so every rapidly dividing tissue depends on it — including the developing follicle, the oocyte and the early embryo. Inadequate folate impairs DNA synthesis and repair precisely when cell division rates are highest. It also feeds the methylation cycle. Folate converts homocysteine back to methionine and thence to S-adenosylmethionine, the universal methyl donor for DNA and histone methylation. Low folate raises homocysteine, and elevated homocysteine in follicular fluid has been associated with poorer oocyte quality, which is the most plausible route from folate status to fertility outcomes.

    Pathways involved

    One-carbon transfer for DNA synthesis
    Purine and thymidylate production
    Homocysteine remethylation to methionine
    DNA and histone methylation
    Follicular and oocyte cell division
    Neural tube closure in early embryogenesis

    Dosing & Protocol

    ScenarioDoseFormTiming
    Standard preconception400 mcg dailyFolic acid or methylfolateFrom at least 1 month before conception
    Higher risk (previous NTD, diabetes, epilepsy medication, BMI over 30)5 mg dailyFolic acidClinician-directed
    Assisted reproduction400-800 mcg dailyFolic acid or methylfolateDaily through the cycle
    Upper limit from supplements1000 mcg dailyFolic acidUnless clinically directed higher
    1. 1

      Start at least a month before trying· Month -1

      Red cell folate takes weeks to rise, and the neural tube closes before most people know they are pregnant.

    2. 2

      Take 400 mcg daily· Ongoing

      A single daily dose, with or without food. Continue through the first twelve weeks of pregnancy at minimum.

    3. 3

      Check whether you need 5 mg· Before starting

      Previous neural tube defect, diabetes, coeliac disease, certain antiepileptics, sickle cell disease or BMI over 30 all shift the recommendation upward. This is a clinician decision.

    4. 4

      Do not treat it as a fertility drug· After 6-12 months

      Folate supports the biology of conception; it does not correct tubal, ovulatory or male-factor infertility. Investigate persistent difficulty conceiving.

    Folic acid or methylfolate?

    Folic acid is the form used in every trial that established the neural tube benefit and is what guidelines specify. Methylfolate is a reasonable alternative and may suit people with MTHFR variants, but it does not have the same outcome evidence behind it.

    Evidence

    The foundational evidence is the randomised trial work showing periconceptional folic acid reduces neural tube defect recurrence and occurrence by a large margin, findings strong enough to have driven mandatory fortification in many countries. That effect is not in dispute. For fertility specifically the evidence is a step weaker. Prospective cohorts such as the Nurses' Health Study associate higher folate intake with less ovulatory infertility, and secondary analyses of assisted reproduction cohorts link higher folate status to more mature oocytes and higher live birth rates. These are observational and subject to confounding by overall diet and health behaviour. No individual trials are linked to this pairing in our database yet, so this reflects the wider literature rather than pair-specific citations.
    Strongest evidence
    Randomised trials of periconceptional folic acid for neural tube defect prevention
    Fertility-specific evidence
    Observational cohorts and secondary analyses of ART outcomes
    Standard dose
    400 mcg daily, 5 mg in higher-risk situations
    Timing
    From at least one month before conception
    Certainty of evidence
    High for NTD prevention, low to moderate for fertility endpoints

    Safety

    High-dose folate can mask B12 deficiency

    Folic acid corrects the anaemia of B12 deficiency while the neurological damage continues undetected. Anyone on 5 mg daily, vegan, over 60, or taking metformin long-term should have B12 status checked.

    Points to watch

    Masking of vitamin B12 deficiency
    Rare hypersensitivity reactions
    Interaction with antiepileptic drug levels
    Nausea at very high doses

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Methotrexate
    high
    Direct folate antagonist; folate supplementation is usually prescribed with it but timing mattersFollow the prescribing clinician's schedule exactly
    Antiepileptics (phenytoin, carbamazepine, valproate)
    moderate
    Two-way interaction — drugs lower folate, folate can lower drug levelsSpecialist supervision; higher folate dose often indicated
    Sulfasalazine
    moderate
    Inhibits intestinal folate absorptionSupplementation usually needed; discuss dose
    Metformin
    moderate
    Long-term use lowers B12, which folate can maskCheck B12 status periodically
    Trimethoprim
    moderate
    Dihydrofolate reductase inhibitionAvoid in early pregnancy where possible; clinician review

    References

    1. De-Regil LM et al. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2015
    2. Gaskins AJ, Chavarro JE. Diet and fertility: a review. Am J Obstet Gynecol. 2018

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.